European regulators have finally approved the Alzheimer’s treatment Leqembi after an advisory committee initially rejected ...

People with special needs often have to drive hours to find a dentist who will see them. New grants are creating more options around California.

A scientific review confirms that poor sleep alters the metabolism of many cells, such as neurons, in a similar way to what ...

gmail.com Objective To examine neuroanatomical changes associated with depressive symptoms in Alzheimer's disease (AD) and the relationship between brain structure and cerebrospinal fluid (CSF) AD ...

Alzheimer’s disease is usually associated with old age. But around 5%-10% of all Alzheimer’s cases occur in people under the age of 65. Early-onset Alzheimer’s disease progresses more rapidly and ...

At 72, María Vargas can no longer recall her grandchildren’s names. She’s one of over 30,000 Costa Ricans living with Alzheimer’s disease today—a number that could balloon to more than 150,000 by 2050 ...

Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. This image provided by Eli Lilly shows the company ...

Lilly plans to seek re-examination of the CHMP's opinion. There are about 7 million people with Alzheimer's disease in Europe, according to the European Brain Council. "It is difficult to ...

Eli Lilly’s Alzheimer’s drug Kisunla has received a negative opinion from the European Union’s drug evaluation board. Meanwhile, competitors Biogen and Eisai are still fighting for market access for ...

The U.S. government has funded university research for nearly 80 years, with a significant share of this funding supporting the fixed costs of science through indirect cost recovery (ICR). We explain ...